ARYx Therapeutics Inc ARYX:Over The Counter Market

Last Price$0.0023Over The Counter Market Previous Close - Last Trade as of 11:07AM ET 9/24/21
Over The Counter Market 15-minute delayed Bid/Ask Quotes
Today's Change0.00(0.00%)
Bid (Size)$0.0022 (10,000)
Ask (Size)$0.0061 (110,000)
Day Low / High$0.0023 - 0.0050

View Biotechnology IndustryPeer Comparison as of 09/24/2021


ARYx Therapeutics Inc ( OTC )

Price: $0.0023
Change: 0.00 (0.00%)
Volume: 7.00
11:07AM ET 9/24/2021

Parallax Health Sciences Inc ( OTC )

Price: $0.0001
Change: 0.00 (0.00%)
Volume: 10.00
10:19AM ET 11/08/2021

Anthera Pharmaceuticals Inc ( OTC )

Price: $0.0001
Change: -0.0001 (50.00%)
Volume: 156.0 K
9:38AM ET 12/01/2021

Integrated Pharmaceuticals Inc ( OTC )

Price: $0.0001
Change: 0.00 (0.00%)
Volume: 15.1 K
12:06PM ET 10/28/2021

Response Genetics Inc ( OTC )

Price: $0.0001
Change: 0.00 (0.00%)
Volume: 1.6 K
9:50AM ET 11/17/2021

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionARYx Therapeutics, Inc. discovers and develops drugs for large, chronic disease markets. Its products include Naronapride, a proprietary serotonin type 4 (5HT4) for the treatment of multiple gastrointestinal disorders; Budiodarone is a proprietary compound in Phase 2 development for the treatment of atrial fibrillation; Tecarfarin, a novel compound for oral anti-coagulation therapy; and ATI-9242, a typical antipsychotic for the treatment of schizophrenia and other psychiatric disorders. The company was founded on February 28, 1997 by Peter G. Milner and Pascal Druzgala and is headquartered in Fremont, CA. View company web site for more details
Address6300 Dumbarton Circle
Fremont, California 94555
Number of Employees56

Company Highlights

Price Open$0.0023
Previous Close$0.0023
52 Week Range$0.0023 - 0.05
Market Capitalization$77.0 K
Shares Outstanding33.5 M
SectorHealth Technology
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.57
Beta vs. S&P 500N/A
Net Profit MarginN/A
Return on Equity386.08%

Analyst Ratings as of 06/10/2010

Consensus RecommendationConsensus Icon
Powered by Factset